Detalhe da pesquisa
1.
An integrated approach to uncover drivers of cancer.
Cell
; 143(6): 1005-17, 2010 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21129771
2.
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.
Mol Cancer
; 13: 141, 2014 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894453
3.
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.
Mol Cancer Ther
; 14(5): 1224-35, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724664
4.
Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency.
PLoS One
; 8(9): e74950, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24066160
5.
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
Cancer Discov
; 2(1): 82-93, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22585170
6.
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
J Clin Oncol
; 29(22): 3085-96, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21383288
7.
p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.
Mol Cell Biol
; 29(19): 5377-88, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19635806
8.
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
Cancer Cell
; 16(1): 21-32, 2009 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19573809